Understanding how nutrients and signals control cell growth and metabolism
Official title: mTORC1 Regulation by Upstream Stimuli
Funded at Ut Southwestern Medical Center · NIH-11052570 · Data updated 2026-11-12
This study is looking at how certain signals in the body affect a protein complex called mTORC1, which is important for cell growth and metabolism, to find new ways to help treat conditions like type 2 diabetes and some cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $42,781 |
| NIH project number | 3R35GM149351-02S1 |
| Project ID | NIH-11052570 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with adult-onset diabetes or related metabolic disorders.
✕Less likely to help
Patients with conditions unrelated to mTORC1 regulation or those not diagnosed with metabolic disorders may not benefit from this research.
What this research studies
This research investigates how the mTORC1 protein complex, which plays a key role in regulating cell growth and metabolism, is influenced by various upstream signals, particularly amino acids and G-protein coupled receptors. By exploring these regulatory mechanisms, the research aims to identify new therapeutic targets that could help manage diseases associated with elevated mTORC1 activity, such as type 2 diabetes and certain cancers. Patients may benefit from insights that could lead to improved treatments for these conditions.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better manage or treat conditions like type 2 diabetes and cancer.
How similar studies have gone: Previous research has shown that targeting mTORC1 can be effective in treating certain diseases, indicating a promising avenue for further exploration.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Jewell, Jenna L — Ut Southwestern Medical Center
- Study coordinator: Jewell, Jenna L
Related research
Other NIH-funded projects on the same topics.
-
Developing targeted therapies for Ewing sarcoma
This study is working on new treatments for Ewing sarcoma, a cancer that mainly affects kids and teens, by finding ways to target a specific protein that helps the cancer grow, so that we can offer safer and better options for those fighting this disease.
-
Neural roots of how autistic adults understand word meaning
A study to understand how adults with autism process word meanings in the brain, aiming to improve language support.
-
A new approach to healing NF1-related tibia fractures in children
This grant aims to understand why some NF1-related leg fractures in kids don’t heal well and to develop better treatments to help them recover without complications.
-
Multi-center study on how ventilation during CPR relates to cardiac arrest outcomes
A large, real-world study will look at how ventilation during CPR affects survival after out-of-hospital cardiac arrest in adults.
-
National Spina Bifida Patient Registry across the U.S.
A national registry collects health information from people with spina bifida to help doctors and families get better, more consistent care.
-
MONA-LISA: Understanding Why Autoimmune Signals Turn into Lupus Over Time
A study using data and samples from people with early autoimmune signs to understand why some develop full-blown lupus and others do not.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.